B

Britannia Life Sciences Inc
CNSX:BLAB

Watchlist Manager
Britannia Life Sciences Inc
CNSX:BLAB
Watchlist
Price: 0.09 CAD Market Closed
Market Cap: 14.6m CAD

Intrinsic Value

The intrinsic value of one BLAB stock under the Base Case scenario is 0.06 CAD. Compared to the current market price of 0.09 CAD, Britannia Life Sciences Inc is Overvalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BLAB Intrinsic Value
0.06 CAD
Overvaluation 32%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation History
Britannia Life Sciences Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about BLAB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BLAB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Britannia Life Sciences Inc.

Explain Valuation
Compare BLAB to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BLAB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Britannia Life Sciences Inc

Current Assets 8.2m
Cash & Short-Term Investments 6.1m
Receivables 201.6k
Other Current Assets 1.8m
Non-Current Assets 1.7m
Long-Term Investments 1.5m
PP&E 128.1k
Current Liabilities 2.6m
Accounts Payable 2.4m
Short-Term Debt 123.7k
Other Current Liabilities 76.6k
Non-Current Liabilities 1.6m
Long-Term Debt 1.6m
Efficiency

Free Cash Flow Analysis
Britannia Life Sciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Britannia Life Sciences Inc

Revenue
3.9m CAD
Cost of Revenue
-1.5m CAD
Gross Profit
2.4m CAD
Operating Expenses
-2.3m CAD
Operating Income
35k CAD
Other Expenses
-2.1m CAD
Net Income
-2m CAD
Fundamental Scores

BLAB Profitability Score
Profitability Due Diligence

Britannia Life Sciences Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
42/100
Profitability
Score

Britannia Life Sciences Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

BLAB Solvency Score
Solvency Due Diligence

Britannia Life Sciences Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Low D/E
Long-Term Solvency
58/100
Solvency
Score

Britannia Life Sciences Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BLAB Price Targets Summary
Britannia Life Sciences Inc

There are no price targets for BLAB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Britannia Life Sciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BLAB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one BLAB stock?

The intrinsic value of one BLAB stock under the Base Case scenario is 0.06 CAD.

Is BLAB stock undervalued or overvalued?

Compared to the current market price of 0.09 CAD, Britannia Life Sciences Inc is Overvalued by 32%.

Back to Top